v3.21.2

Significant Transactions (Summary of Asset Acquisition) (Details)	Aug. 23, 2021 USD ($)
Purchase price allocated	$ 7,500,000
Series A-2 Preferred Stock [Member]
Purchase price allocated	1,760,000
Intangible Assets [Member]
Purchase price allocated	4,300,000
Prepaid Expenses [Member]
Purchase price allocated	1,440,000
Immune-Oncology Antibodies (RTX-003) [Member] | RubrYc Theraputics, Inc. [Member]
Purchase price allocated	$ 7,500,000

X

- Definition

Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.

+ References

No definition available.

+ Details

Name:	ibio_AssetAcquisitionConsiderationTransferred
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	ibio_AssetAcquisitionAxis=ibio_Series2PreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ibio_AssetAcquisitionAxis=us-gaap_FiniteLivedIntangibleAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ibio_AssetAcquisitionAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=ibio_ImmuneOncologyAntibodiesRtx003Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_CounterpartyNameAxis=ibio_RubrycTheraputicsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: